Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast Add-On in Rheumatoid Arthritis
NCT07632846Phase 2Recruiting
- Sponsor
- Horus Pharma
- Start
- May 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of roflumilast in rheumatoid arthritis (RA), sponsored by Horus Pharma. Started May 2026; status: recruiting.
02
Drugs
roflumilast
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07632846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07632846.